Trial reportThe American journal of psychiatry2023
A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT.
Trial report in The American journal of psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 21 citations in OpenAlex.
- Characterizing social motivation deficits in treatment-resistant schizophrenia: Evidence from social incentive performance.Psychiatry and clinical neurosciences · 2026Article
- Cognitive behavioral therapy targeting persecutory delusions in chronic outpatients with schizophrenia: a randomized controlled trial on functional recovery and symptom severity.Frontiers in medicine · 2026Article
- Advances in implementation strategies for treatment adherence in schizophrenia: a narrative review.Frontiers in psychiatry · 2026Review
- The temporal relationships between social motivation and social interactions in people with serious mental illness and recent homelessness.Journal of mental health (Abingdon, England) · 2025Article
- Cognitive-behavioral Therapy for Schizophrenia: A Bibliometric and Scientometric Study of Global Evidence, Gaps, and Emerging Themes.The Psychiatric quarterly · 2025Article
- Acceptance and commitment therapy applied to early psychosis: Therapeutic foundations and a narrative systematic review.World journal of psychiatry · 2025Article
- Psychosocial Interventions Impact on Cardiometabolic, Neurobiological, Behavioral, and Immune Outcomes in People With a Serious Mental Illness: A Systematic Review.Health science reports · 2025Review
- Using pupillometry to predict outcome in cognitive behavioral therapy for negative symptoms of schizophrenia.Schizophrenia research · 2025Article
- Using machine learning to understand social isolation and loneliness in schizophrenia, bipolar disorder, and the community.Schizophrenia (Heidelberg, Germany) · 2024Article
- Psychosocial and psychological interventions for schizophrenia relapse prevention: A bibliometric analysis.Global mental health (Cambridge, England) · 2024Article
- Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study.Schizophrenia (Heidelberg, Germany) · 2023Article
- Social Motivation in Schizophrenia: What's Effort Got to Do With It?Schizophrenia bulletin · 2023Review
- Treating Pathologies of the Will.The American journal of psychiatry · 2023Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveNegative symptoms are a primary cause of disability in schizophrenia for which there are no established pharmacotherapies. This study evaluated a novel psychosocial intervention that combined two evidence-based practices-motivational interviewing and cognitive-behavioral therapy (MI-CBT)-for the treatment of motivational negative symptoms.
methodsSeventy-nine participants with schizophrenia and moderate to severe negative symptoms were included in a randomized controlled trial comparing the 12-session MI-CBT treatment with a mindfulness control condition. Participants were assessed at three time points through the study period, which included 12 weeks of active treatment and 12 weeks of follow-up. The primary outcome measures were motivational negative symptoms and community functioning; the secondary outcomes included a posited biomarker of negative symptoms: pupillometric response to cognitive effort.
resultsCompared with the control group, participants in the MI-CBT group showed significantly greater improvements in motivational negative symptoms over the acute treatment period. Their gains relative to baseline were maintained at follow-up, although the differential benefit relative to control subjects was attenuated. There were nonsignificant effects toward improvements in community functioning and differential change in the pupillometric markers of cognitive effort.
conclusionsThe results show that combining motivational interviewing with CBT yields improvements in negative symptoms, a feature of schizophrenia generally thought of as resistant to intervention. Motivational negative symptoms not only responded to the novel treatment, but the gains were maintained over the follow-up period. Implications for future studies and for improving the generalization of the negative symptom gains to daily functioning domains are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.